| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mucosa | 13 | 2013 | 90 | 2.610 |
Why?
|
| Epithelial Cells | 23 | 2015 | 704 | 2.300 |
Why?
|
| Asthma | 17 | 2019 | 1051 | 2.050 |
Why?
|
| HLA-G Antigens | 6 | 2017 | 52 | 1.770 |
Why?
|
| Trachea | 24 | 2003 | 293 | 1.690 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2017 | 133 | 1.180 |
Why?
|
| Bronchi | 11 | 2015 | 234 | 1.160 |
Why?
|
| Respiratory System | 5 | 2017 | 120 | 1.150 |
Why?
|
| Wound Healing | 10 | 2009 | 378 | 1.080 |
Why?
|
| Apoptosis | 10 | 2006 | 1756 | 1.030 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2015 | 295 | 0.900 |
Why?
|
| Cell Movement | 12 | 2010 | 816 | 0.860 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2014 | 37 | 0.760 |
Why?
|
| Muscle, Smooth | 14 | 2015 | 358 | 0.720 |
Why?
|
| Microbiota | 2 | 2017 | 425 | 0.680 |
Why?
|
| Cytokines | 3 | 2015 | 871 | 0.630 |
Why?
|
| Cells, Cultured | 23 | 2015 | 2928 | 0.600 |
Why?
|
| Lung | 9 | 2015 | 1380 | 0.560 |
Why?
|
| Muscle Contraction | 13 | 1997 | 294 | 0.560 |
Why?
|
| Lung Transplantation | 2 | 2014 | 367 | 0.550 |
Why?
|
| Eosinophils | 11 | 2017 | 196 | 0.540 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 358 | 0.540 |
Why?
|
| Interleukin-6 | 1 | 2019 | 281 | 0.540 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 121 | 0.480 |
Why?
|
| Dexamethasone | 3 | 2015 | 350 | 0.480 |
Why?
|
| Bacteria | 2 | 2017 | 516 | 0.480 |
Why?
|
| Guinea Pigs | 19 | 2003 | 172 | 0.460 |
Why?
|
| Postoperative Complications | 3 | 2016 | 2603 | 0.460 |
Why?
|
| Catheter Ablation | 3 | 2015 | 365 | 0.450 |
Why?
|
| Prednisone | 1 | 2015 | 252 | 0.440 |
Why?
|
| Chemotaxis | 5 | 1999 | 74 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2005 | 224 | 0.400 |
Why?
|
| Calcitonin Gene-Related Peptide | 5 | 1999 | 39 | 0.390 |
Why?
|
| Glucocorticoids | 3 | 2015 | 369 | 0.390 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 454 | 0.390 |
Why?
|
| Immunomodulation | 1 | 2013 | 64 | 0.380 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1662 | 0.360 |
Why?
|
| Th2 Cells | 1 | 2013 | 151 | 0.360 |
Why?
|
| Neuromuscular Diseases | 1 | 2012 | 29 | 0.360 |
Why?
|
| Neuropeptides | 3 | 2001 | 116 | 0.340 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2011 | 179 | 0.340 |
Why?
|
| Humans | 57 | 2019 | 95992 | 0.330 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2010 | 7 | 0.330 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2010 | 9 | 0.330 |
Why?
|
| Peptides | 3 | 2001 | 671 | 0.330 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 161 | 0.320 |
Why?
|
| Cyclosporine | 1 | 2011 | 242 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 206 | 0.320 |
Why?
|
| Lectins | 3 | 2007 | 84 | 0.320 |
Why?
|
| Ribonucleases | 4 | 1996 | 97 | 0.310 |
Why?
|
| Blood Proteins | 4 | 1996 | 151 | 0.310 |
Why?
|
| Inflammation | 1 | 2015 | 1063 | 0.300 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 205 | 0.300 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 56 | 0.300 |
Why?
|
| Male | 40 | 2019 | 45792 | 0.290 |
Why?
|
| Interleukin-4 | 1 | 2009 | 135 | 0.290 |
Why?
|
| Immune Tolerance | 1 | 2011 | 385 | 0.290 |
Why?
|
| Transcription Factor RelA | 1 | 2008 | 49 | 0.290 |
Why?
|
| Cell Line | 8 | 2009 | 2536 | 0.290 |
Why?
|
| Graft Rejection | 1 | 2014 | 1127 | 0.280 |
Why?
|
| Epithelium | 12 | 2006 | 322 | 0.280 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.280 |
Why?
|
| Bombesin | 2 | 1999 | 6 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 2059 | 0.270 |
Why?
|
| Budesonide | 2 | 2014 | 46 | 0.270 |
Why?
|
| Animals | 41 | 2014 | 28901 | 0.260 |
Why?
|
| Cell Division | 8 | 2003 | 701 | 0.250 |
Why?
|
| Forced Expiratory Volume | 3 | 2015 | 136 | 0.240 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 997 | 0.240 |
Why?
|
| fas Receptor | 3 | 2004 | 76 | 0.230 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 259 | 0.230 |
Why?
|
| Female | 26 | 2019 | 49980 | 0.220 |
Why?
|
| Acetylcholine | 9 | 1997 | 180 | 0.220 |
Why?
|
| Stress, Mechanical | 3 | 2010 | 261 | 0.220 |
Why?
|
| Adult | 13 | 2019 | 28636 | 0.220 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 153 | 0.210 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2003 | 76 | 0.210 |
Why?
|
| Middle Aged | 15 | 2019 | 28299 | 0.210 |
Why?
|
| Bronchoscopy | 3 | 2015 | 175 | 0.210 |
Why?
|
| Epidermal Growth Factor | 3 | 1999 | 116 | 0.210 |
Why?
|
| Receptors, Very Late Antigen | 3 | 1999 | 6 | 0.200 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2003 | 36 | 0.200 |
Why?
|
| Stress Fibers | 1 | 2003 | 24 | 0.200 |
Why?
|
| Cytoskeleton | 2 | 2003 | 200 | 0.200 |
Why?
|
| 3T3 Cells | 2 | 2003 | 98 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 2 | 2001 | 227 | 0.190 |
Why?
|
| Prostaglandins | 2 | 1993 | 44 | 0.190 |
Why?
|
| Phospholipases A | 2 | 1993 | 45 | 0.190 |
Why?
|
| Endothelins | 2 | 1992 | 26 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 349 | 0.180 |
Why?
|
| Mucins | 1 | 2001 | 40 | 0.180 |
Why?
|
| Growth Substances | 1 | 2001 | 79 | 0.180 |
Why?
|
| Actins | 2 | 2003 | 472 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2004 | 446 | 0.170 |
Why?
|
| Ganglia, Spinal | 3 | 1997 | 76 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2009 | 1156 | 0.170 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2014 | 93 | 0.170 |
Why?
|
| Depsipeptides | 1 | 2001 | 32 | 0.170 |
Why?
|
| Peroxidases | 4 | 1994 | 34 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2001 | 134 | 0.170 |
Why?
|
| Biomarkers | 3 | 2017 | 1931 | 0.160 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2009 | 31 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1982 | 0.150 |
Why?
|
| Polylysine | 3 | 1997 | 34 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 1999 | 477 | 0.150 |
Why?
|
| Immunoglobulin E | 2 | 2017 | 152 | 0.150 |
Why?
|
| Sympathetic Nervous System | 2 | 1990 | 99 | 0.150 |
Why?
|
| Integrin beta1 | 1 | 1999 | 34 | 0.150 |
Why?
|
| Kinetics | 10 | 2001 | 1561 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2014 | 1966 | 0.150 |
Why?
|
| Allergens | 2 | 2014 | 191 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1267 | 0.140 |
Why?
|
| Phenotype | 4 | 2019 | 2575 | 0.140 |
Why?
|
| Wounds, Stab | 1 | 1997 | 12 | 0.140 |
Why?
|
| Pneumonia | 2 | 1998 | 196 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2011 | 89 | 0.130 |
Why?
|
| Sputum | 1 | 2017 | 36 | 0.130 |
Why?
|
| Databases, Genetic | 2 | 2015 | 283 | 0.130 |
Why?
|
| Neurokinin B | 1 | 1997 | 1 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 76 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 113 | 0.130 |
Why?
|
| Flow Cytometry | 5 | 1999 | 725 | 0.130 |
Why?
|
| Metabolome | 1 | 2017 | 63 | 0.130 |
Why?
|
| Metered Dose Inhalers | 1 | 2017 | 33 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 102 | 0.120 |
Why?
|
| Vital Capacity | 1 | 2016 | 74 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 253 | 0.120 |
Why?
|
| Gastrostomy | 1 | 2016 | 69 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 105 | 0.120 |
Why?
|
| Knowledge Bases | 1 | 2015 | 15 | 0.120 |
Why?
|
| Integrative Medicine | 1 | 2015 | 10 | 0.120 |
Why?
|
| Bradykinin | 2 | 1993 | 46 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2017 | 281 | 0.120 |
Why?
|
| Tachykinins | 1 | 1995 | 13 | 0.120 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 112 | 0.110 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2015 | 19 | 0.110 |
Why?
|
| Time Factors | 5 | 2014 | 5593 | 0.110 |
Why?
|
| Eosinophilia | 1 | 2015 | 88 | 0.110 |
Why?
|
| Dogs | 8 | 2001 | 718 | 0.110 |
Why?
|
| In Vitro Techniques | 9 | 1997 | 1014 | 0.110 |
Why?
|
| Laminin | 3 | 2001 | 92 | 0.110 |
Why?
|
| Nedocromil | 1 | 2014 | 6 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 42 | 0.110 |
Why?
|
| alpha-N-Acetylgalactosaminidase | 1 | 2014 | 4 | 0.110 |
Why?
|
| Serotonin | 4 | 1993 | 219 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 37 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2014 | 17 | 0.110 |
Why?
|
| Pregnenediones | 1 | 2014 | 8 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 126 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cholecalciferol | 1 | 2014 | 35 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2001 | 796 | 0.100 |
Why?
|
| Diaphragm | 1 | 2014 | 75 | 0.100 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Solubility | 1 | 2014 | 190 | 0.100 |
Why?
|
| Vitamins | 1 | 2014 | 86 | 0.100 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 7 | 1997 | 39 | 0.100 |
Why?
|
| Rhinovirus | 1 | 2013 | 29 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 378 | 0.100 |
Why?
|
| Cell Cycle | 1 | 1995 | 516 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 306 | 0.100 |
Why?
|
| Mast Cells | 2 | 2014 | 97 | 0.100 |
Why?
|
| Potassium Chloride | 3 | 1997 | 88 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2009 | 22 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 107 | 0.100 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2015 | 210 | 0.100 |
Why?
|
| Neurons | 3 | 1997 | 1654 | 0.090 |
Why?
|
| Cytochalasin D | 2 | 2003 | 15 | 0.090 |
Why?
|
| Acute Disease | 1 | 2014 | 859 | 0.090 |
Why?
|
| Virus Replication | 1 | 2013 | 326 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 258 | 0.090 |
Why?
|
| Cell Line, Transformed | 3 | 2007 | 156 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1210 | 0.090 |
Why?
|
| Histamine | 2 | 1989 | 124 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 174 | 0.090 |
Why?
|
| Bronchoconstriction | 1 | 1991 | 56 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 241 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 776 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 604 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 655 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 487 | 0.080 |
Why?
|
| Swine | 2 | 1990 | 607 | 0.080 |
Why?
|
| Rats | 6 | 2009 | 4155 | 0.080 |
Why?
|
| Chemokine CCL26 | 1 | 2010 | 1 | 0.080 |
Why?
|
| Chemokines, CC | 1 | 2010 | 37 | 0.080 |
Why?
|
| Acidosis | 1 | 1990 | 56 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 106 | 0.080 |
Why?
|
| Eosinophil Granule Proteins | 4 | 1996 | 20 | 0.080 |
Why?
|
| Hypercapnia | 1 | 1990 | 49 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2015 | 984 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2010 | 126 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 190 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1533 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 1766 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2009 | 29 | 0.080 |
Why?
|
| Vasomotor System | 1 | 1989 | 13 | 0.080 |
Why?
|
| Isoproterenol | 2 | 1989 | 63 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 2009 | 115 | 0.070 |
Why?
|
| Air | 1 | 2009 | 63 | 0.070 |
Why?
|
| Sympathomimetics | 1 | 1989 | 12 | 0.070 |
Why?
|
| Antigens, Helminth | 1 | 1989 | 22 | 0.070 |
Why?
|
| Histamine Release | 1 | 1989 | 53 | 0.070 |
Why?
|
| Young Adult | 2 | 2019 | 7034 | 0.070 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2008 | 32 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 284 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 68 | 0.070 |
Why?
|
| Hypotension | 1 | 1989 | 76 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2009 | 394 | 0.070 |
Why?
|
| Substance P | 3 | 1999 | 62 | 0.070 |
Why?
|
| Muscle Relaxation | 1 | 1988 | 18 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 65 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2016 | 1541 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 89 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1989 | 116 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 591 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2001 | 430 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 127 | 0.070 |
Why?
|
| Neurokinin A | 3 | 1999 | 12 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 897 | 0.070 |
Why?
|
| Aged | 6 | 2017 | 20927 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2015 | 4690 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2009 | 692 | 0.070 |
Why?
|
| Insulin | 3 | 1999 | 1191 | 0.070 |
Why?
|
| Microscopy, Video | 2 | 1998 | 36 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 183 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 307 | 0.070 |
Why?
|
| Annexin A2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Gene Expression | 2 | 2004 | 1319 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 562 | 0.070 |
Why?
|
| Collagen | 2 | 1999 | 306 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 516 | 0.060 |
Why?
|
| Mice | 4 | 2014 | 12525 | 0.060 |
Why?
|
| Epinephrine | 3 | 1992 | 92 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2495 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1992 | 173 | 0.060 |
Why?
|
| Capsaicin | 4 | 1999 | 45 | 0.060 |
Why?
|
| Fibronectins | 2 | 1998 | 100 | 0.060 |
Why?
|
| Receptors, Tachykinin | 2 | 1995 | 9 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2017 | 203 | 0.060 |
Why?
|
| Culture Media | 2 | 1998 | 149 | 0.060 |
Why?
|
| Dinoprostone | 2 | 1997 | 75 | 0.060 |
Why?
|
| Mucous Membrane | 2 | 1997 | 85 | 0.060 |
Why?
|
| Glycosylation | 2 | 2007 | 137 | 0.050 |
Why?
|
| Eosinophil Peroxidase | 3 | 1994 | 14 | 0.050 |
Why?
|
| Smad7 Protein | 1 | 2004 | 8 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2000 | 1425 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2004 | 128 | 0.050 |
Why?
|
| Cyclin E | 1 | 2004 | 28 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 211 | 0.050 |
Why?
|
| Cytochalasin B | 5 | 1997 | 19 | 0.050 |
Why?
|
| Benzamides | 2 | 1995 | 248 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 80 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2004 | 85 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 79 | 0.050 |
Why?
|
| Piperidines | 2 | 1995 | 171 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 32 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 209 | 0.050 |
Why?
|
| Amides | 1 | 2003 | 56 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2004 | 228 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2014 | 297 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2003 | 687 | 0.050 |
Why?
|
| Phospholipases A2 | 2 | 1993 | 44 | 0.050 |
Why?
|
| Acetophenones | 2 | 1993 | 27 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2003 | 110 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 124 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 162 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 648 | 0.050 |
Why?
|
| Trefoil Factor-2 | 1 | 2001 | 2 | 0.040 |
Why?
|
| Trefoil Factor-3 | 1 | 2001 | 2 | 0.040 |
Why?
|
| Bronchitis, Chronic | 1 | 2001 | 3 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1176 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1080 | 0.040 |
Why?
|
| Steroids | 1 | 2002 | 173 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 144 | 0.040 |
Why?
|
| Pyridines | 1 | 2003 | 319 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 2474 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 396 | 0.040 |
Why?
|
| Receptors, Fibronectin | 1 | 2001 | 4 | 0.040 |
Why?
|
| Vinculin | 1 | 2001 | 9 | 0.040 |
Why?
|
| Receptors, Laminin | 1 | 2001 | 6 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2001 | 35 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2001 | 49 | 0.040 |
Why?
|
| Dystroglycans | 1 | 2001 | 15 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1006 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2001 | 44 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2001 | 148 | 0.040 |
Why?
|
| Paxillin | 1 | 2001 | 59 | 0.040 |
Why?
|
| Caspases | 1 | 2001 | 156 | 0.040 |
Why?
|
| Focal Adhesions | 1 | 2001 | 66 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 1124 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 326 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 1997 | 535 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2014 | 1792 | 0.040 |
Why?
|
| DNA Primers | 1 | 2001 | 548 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2014 | 10307 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2001 | 263 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 3581 | 0.040 |
Why?
|
| Nose Neoplasms | 1 | 1999 | 36 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 1999 | 36 | 0.040 |
Why?
|
| Leucine | 1 | 1999 | 62 | 0.040 |
Why?
|
| Glycoconjugates | 1 | 1999 | 11 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1999 | 130 | 0.040 |
Why?
|
| Nasal Polyps | 1 | 1999 | 64 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 242 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2004 | 77 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 50 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1997 | 1267 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 930 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2001 | 513 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1999 | 130 | 0.040 |
Why?
|
| Atropine | 2 | 1996 | 61 | 0.030 |
Why?
|
| Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 1997 | 3 | 0.030 |
Why?
|
| Prostaglandin Antagonists | 1 | 1997 | 8 | 0.030 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1997 | 5 | 0.030 |
Why?
|
| Xanthones | 1 | 1997 | 11 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 481 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 283 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2001 | 911 | 0.030 |
Why?
|
| Receptors, Bombesin | 1 | 1997 | 2 | 0.030 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 1997 | 4 | 0.030 |
Why?
|
| Leukotriene C4 | 2 | 1994 | 21 | 0.030 |
Why?
|
| Glycopeptides | 1 | 1997 | 18 | 0.030 |
Why?
|
| Neprilysin | 1 | 1997 | 41 | 0.030 |
Why?
|
| Platelet Activating Factor | 3 | 1997 | 53 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 18 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2017 | 50 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 72 | 0.030 |
Why?
|
| Self Administration | 1 | 2017 | 76 | 0.030 |
Why?
|
| Regeneration | 1 | 1997 | 160 | 0.030 |
Why?
|
| Indomethacin | 2 | 1997 | 62 | 0.030 |
Why?
|
| Child | 3 | 2014 | 7621 | 0.030 |
Why?
|
| Proteins | 1 | 2001 | 816 | 0.030 |
Why?
|
| Cations | 1 | 1996 | 32 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 40 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 1996 | 66 | 0.030 |
Why?
|
| Kidney | 1 | 2001 | 1135 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 78 | 0.030 |
Why?
|
| Peroxidase | 2 | 1993 | 54 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1995 | 58 | 0.030 |
Why?
|
| Data Mining | 1 | 2015 | 44 | 0.030 |
Why?
|
| S Phase | 1 | 1995 | 64 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 1995 | 35 | 0.030 |
Why?
|
| Genes | 1 | 2015 | 307 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 35 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 26 | 0.030 |
Why?
|
| Costa Rica | 1 | 2014 | 16 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 600 | 0.030 |
Why?
|
| Epidermis | 1 | 2014 | 104 | 0.030 |
Why?
|
| Cell Communication | 1 | 1995 | 220 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2014 | 66 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2014 | 146 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1191 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1994 | 39 | 0.030 |
Why?
|
| Thymidine | 1 | 1993 | 59 | 0.030 |
Why?
|
| Blood Cells | 1 | 1993 | 32 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 348 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 701 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1993 | 18 | 0.020 |
Why?
|
| Quinacrine | 1 | 1993 | 10 | 0.020 |
Why?
|
| SRS-A | 1 | 1993 | 27 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 358 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1993 | 113 | 0.020 |
Why?
|
| ROC Curve | 1 | 1996 | 799 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 526 | 0.020 |
Why?
|
| Propranolol | 2 | 1994 | 44 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 65 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1993 | 95 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1018 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 321 | 0.020 |
Why?
|
| Superoxides | 1 | 1993 | 76 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 367 | 0.020 |
Why?
|
| Interferons | 1 | 2013 | 119 | 0.020 |
Why?
|
| Interleukins | 1 | 2013 | 134 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 126 | 0.020 |
Why?
|
| Cell Separation | 1 | 1993 | 205 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 63 | 0.020 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1992 | 4 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 686 | 0.020 |
Why?
|
| Eicosanoids | 1 | 1992 | 17 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1998 | 2088 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 176 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 1992 | 48 | 0.020 |
Why?
|
| Chloralose | 1 | 1992 | 6 | 0.020 |
Why?
|
| Dinoprost | 1 | 1992 | 27 | 0.020 |
Why?
|
| Medicare | 1 | 1996 | 458 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 522 | 0.020 |
Why?
|
| Epoprostenol | 1 | 1992 | 46 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 1992 | 61 | 0.020 |
Why?
|
| Amitrole | 1 | 1991 | 3 | 0.020 |
Why?
|
| Iliac Artery | 1 | 1992 | 42 | 0.020 |
Why?
|
| Comorbidity | 1 | 1996 | 1017 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1992 | 86 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 1144 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2014 | 504 | 0.020 |
Why?
|
| Neutrophils | 1 | 1993 | 326 | 0.020 |
Why?
|
| Cell Survival | 1 | 1993 | 1029 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 832 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1991 | 64 | 0.020 |
Why?
|
| Homeostasis | 1 | 1993 | 466 | 0.020 |
Why?
|
| Hemodynamics | 2 | 1992 | 776 | 0.020 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1992 | 248 | 0.020 |
Why?
|
| Chromones | 1 | 2009 | 31 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 48 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 2385 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1959 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1827 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 139 | 0.020 |
Why?
|
| Genomics | 1 | 2015 | 857 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2160 | 0.020 |
Why?
|
| Morpholines | 1 | 2009 | 77 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 76 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 213 | 0.020 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 1989 | 5 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 279 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 509 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1989 | 32 | 0.020 |
Why?
|
| Ascaris | 1 | 1989 | 5 | 0.020 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 1989 | 8 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 1989 | 19 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1991 | 333 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1996 | 3115 | 0.020 |
Why?
|
| Catecholamines | 1 | 1989 | 92 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 1883 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 2384 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1991 | 425 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1988 | 245 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1988 | 154 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3993 | 0.020 |
Why?
|
| Cicer | 1 | 2007 | 1 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2007 | 14 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2534 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 1996 | 7224 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1989 | 166 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3969 | 0.020 |
Why?
|
| Oxygen | 1 | 1992 | 781 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 478 | 0.010 |
Why?
|
| Muscle Tonus | 2 | 1997 | 20 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 1560 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1997 | 398 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2776 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 9228 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1993 | 36 | 0.010 |
Why?
|
| United States | 1 | 1996 | 7785 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1810 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 848 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 566 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1275 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1999 | 41 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 317 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 1999 | 196 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 675 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1997 | 25 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 1997 | 47 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 1997 | 3 | 0.010 |
Why?
|
| Iloprost | 1 | 1997 | 15 | 0.010 |
Why?
|
| Xanthenes | 1 | 1997 | 23 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1997 | 62 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1997 | 172 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 380 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 712 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1995 | 23 | 0.010 |
Why?
|
| Mannitol | 1 | 1995 | 51 | 0.010 |
Why?
|
| Glycerol | 1 | 1995 | 37 | 0.010 |
Why?
|
| Sucrose | 1 | 1995 | 67 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1995 | 162 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 95 | 0.010 |
Why?
|
| Albuterol | 1 | 1994 | 35 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1993 | 67 | 0.010 |
Why?
|
| L-Selectin | 1 | 1993 | 17 | 0.010 |
Why?
|
| Phenyl Ethers | 1 | 1993 | 13 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1993 | 36 | 0.010 |
Why?
|
| Acetamides | 1 | 1993 | 27 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 128 | 0.010 |
Why?
|
| Adolescent | 2 | 1999 | 9878 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1993 | 91 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1992 | 52 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1992 | 75 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 250 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1992 | 149 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1991 | 43 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 267 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1991 | 52 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1992 | 284 | 0.010 |
Why?
|
| Calcium | 1 | 1995 | 1205 | 0.010 |
Why?
|
| Anesthesia | 1 | 1992 | 175 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1991 | 161 | 0.000 |
Why?
|
| Bucladesine | 1 | 1989 | 13 | 0.000 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1989 | 17 | 0.000 |
Why?
|
| Colforsin | 1 | 1989 | 75 | 0.000 |
Why?
|
| Biological Factors | 1 | 1989 | 18 | 0.000 |
Why?
|
| Phospholipid Ethers | 1 | 1988 | 4 | 0.000 |
Why?
|
| Methysergide | 1 | 1988 | 6 | 0.000 |
Why?
|
| Tachyphylaxis | 1 | 1988 | 14 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1991 | 460 | 0.000 |
Why?
|